EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma

Ashraf Khalil, Azza ElSheashaey, Eman Abdelsameea, Manar Obada, Mohamed Bayomy F F, Hala El-Said

British Journal of Biomedical Science · 2022

DOI: 10.3389/bjbs.2021.10191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Biomedical Science, 2022. Verfasst von Ashraf Khalil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shibin el Kom, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis C, Liver Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabonomic studies have related bile acids to hepatic impairment, but their role in predicting hepatocellular carcinoma still unclear. The study aimed to examine the feasibility of bile acids in distinguishing hepatocellular carcinoma from post hepatitis C virus-induced liver cirrhosis.

Methods

An ultra-performance liquid chromatography coupled with mass spectrometry measured 14 bile acids in patients with noncirrhotic post hepatitis C virus disease (n = 50), cirrhotic post hepatitis C virus disease (n = 50), hepatocellular carcinoma (n = 50), and control group (n = 50).

Results

The spectrum of liver disease was associated with a significant increase in many conjugated bile acids. The fold changes in many bile acid concentrations showed a linear trend with hepatocellular carcinoma > cirrhotic disease > noncirrhotic disease > healthy controls ( p < 0.05). Receiver operating characteristic curve analysis revealed five conjugated acids TCA, GCA, GUDCA, TCDCA, GCDCA, that discriminated hepatocellular carcinoma from noncirrhotic liver patients (AUC = 0.85–0.96) with a weaker potential to distinguish it from chronic liver cirrhosis (AUC = 0.41–0.64).

Conclusion

Serum bile acids are associated primarily with liver cirrhosis with little value in predicting the progress of cirrhotic disease to hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis CLiver NeoplasmsBile Acids and SaltsHepacivirusHumansLiver Cirrhosis

Stichwörter der Autor:innen

bile acidcirrhosishepatocellular carcinomaliquid chromatography-mass spectrometrymetabolic profiling

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shibin el Kom, Egypt.
  • Department of Zoology, Faculty of Science, Menoufia University, Shibin el Kom, Egypt.
  • Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shibin el Kom, Egypt.

Zitieren

APA

Khalil, A., ElSheashaey, A., Abdelsameea, E., Obada, M., Bayomy F F, M., & El-Said, H. (2022). Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma. British Journal of Biomedical Science. https://doi.org/10.3389/bjbs.2021.10191

Vancouver

Khalil A, ElSheashaey A, Abdelsameea E, Obada M, Bayomy F F M, El-Said H. Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma. British Journal of Biomedical Science. 2022. doi:10.3389/bjbs.2021.10191

BibTeX
@article{Khalil2022,
  author = {Khalil, Ashraf and ElSheashaey, Azza and Abdelsameea, Eman and Obada, Manar and Bayomy F F, Mohamed and El-Said, Hala},
  title = {Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma},
  journal = {British Journal of Biomedical Science},
  year = {2022},
  doi = {10.3389/bjbs.2021.10191}
}
Kostenlos starten →